Probi’s largest clinical trial confirms the immune enhancing impact of Probi Defendum® and sheds new light on the mechanism

Probi's largest clinical trial ever, focused on probiotic immune health, has recently been completed. The study included over 900 subjects and was carried out over a period of 3 winter seasons. The randomized, double-blind, placebo-controlled trial confirms the strong clinical immune enhancing effect of Probi Defendum®. The study proves Probi Defendum® to protect against recurrent colds in addition to shedding some light on the mechanism of action behind the effect. Probi Defendum®, a probiotic immune concept based on the combination of Probi’s patented probiotic strains, Lactobacillus